Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (361-370 of 790) with videos related to

Pageof 79
Sort By:
Journal of Clinical Psychopharmacology|April 1, 1997
5-HT3 receptors, nausea, and serotonin reuptake inhibitionN J Coupland, J E Bailey, J P Potokar, et al.
European Journal of Pharmacology|August 17, 1984
Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCMD J Nutt, H J Little, S C Taylor, et al.
Annals of the New York Academy of Sciences|March 19, 2004
Relationship between imidazoline(2) sites and monoamine oxidaseL M Paterson, R J Tyacke, D J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 29, 2010
Measuring endogenous 5-HT release by emission tomography: promises and pitfallsLouise M Paterson, Robin J Tyacke, David J Nutt, et al.
European Journal of Pharmacology|February 24, 1987
A single dose of FG 7142 causes long-term increases in mouse cortical beta-adrenoceptorsS C Stanford, H J Little, D J Nutt, et al.
European Journal of Pharmacology|September 23, 1986
Effects of chronic treatment with benzodiazepine receptor ligands on cortical adrenoceptorsS C Stanford, H J Little, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|May 19, 1998
Integrating the cognitive and physiological aspects of cravingA Weinstein, B Feldtkeller, A Malizia, et al.
Acta Neuropsychiatrica|March 18, 2016
The clinical use of buprenorphine in opiate addiction: evidence and practiceFergus D Law, Judy S Myles, Mark R C Daglish, et al.
Neuropharmacology|September 6, 2002
5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brainR J Tyacke, E S J Robinson, D J Nutt, et al.
Elife|November 9, 2020
Correction: DMT alters cortical travelling wavesAndrea Alamia, Christopher Timmermann, David J Nutt, et al.
Pageof 79

Showing results (361-370 of 790) with videos related to

Sort By:
Pageof 79
Journal of Clinical Psychopharmacology|April 1, 1997
5-HT3 receptors, nausea, and serotonin reuptake inhibitionN J Coupland, J E Bailey, J P Potokar, et al.
European Journal of Pharmacology|August 17, 1984
Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCMD J Nutt, H J Little, S C Taylor, et al.
Annals of the New York Academy of Sciences|March 19, 2004
Relationship between imidazoline(2) sites and monoamine oxidaseL M Paterson, R J Tyacke, D J Nutt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 29, 2010
Measuring endogenous 5-HT release by emission tomography: promises and pitfallsLouise M Paterson, Robin J Tyacke, David J Nutt, et al.
European Journal of Pharmacology|February 24, 1987
A single dose of FG 7142 causes long-term increases in mouse cortical beta-adrenoceptorsS C Stanford, H J Little, D J Nutt, et al.
European Journal of Pharmacology|September 23, 1986
Effects of chronic treatment with benzodiazepine receptor ligands on cortical adrenoceptorsS C Stanford, H J Little, D J Nutt, et al.
Journal of Psychopharmacology (Oxford, England)|May 19, 1998
Integrating the cognitive and physiological aspects of cravingA Weinstein, B Feldtkeller, A Malizia, et al.
Acta Neuropsychiatrica|March 18, 2016
The clinical use of buprenorphine in opiate addiction: evidence and practiceFergus D Law, Judy S Myles, Mark R C Daglish, et al.
Neuropharmacology|September 6, 2002
5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brainR J Tyacke, E S J Robinson, D J Nutt, et al.
Elife|November 9, 2020
Correction: DMT alters cortical travelling wavesAndrea Alamia, Christopher Timmermann, David J Nutt, et al.
Pageof 79